C. Willett

发表

Lessons from Toxicology: Developing a 21st-Century Paradigm for Medical Research

Hiroaki Kitano, Christopher P. Austin, Linda S. Birnbaum, 2015, Environmental health perspectives.

Towards a 21st-century roadmap for biomedical research and drug discovery: consensus report and recommendations.

Martin Hofmann-Apitius, Brigitte Landesmann, Christoph Giese, 2017, Drug discovery today.

Recommendations toward a human pathway-based approach to disease research.

Christopher P. Austin, Catherine Willett, Warren Casey, 2018, Drug discovery today.

Parkinson's disease research: adopting a more human perspective to accelerate advances.

C. Willett, L. Marshall, 2018, Drug discovery today.

The potential of mechanistic information organised within the AOP framework to increase regulatory uptake of the developmental neurotoxicity (DNT) in vitro battery of assays

F. Pistollato, C. Willett, A. Bal-Price, 2021, Reproductive toxicology.

Use of Adverse Outcome Pathways in Human Risk Assessment and Toxicology

S. Fitzpatrick, C. Willett, B. Meek, 2018 .

Application of an integrated testing strategy to the U.S. EPA endocrine disruptor screening program.

Catherine E Willett, Patricia L Bishop, Kristie M Sullivan, 2011, Toxicological sciences : an official journal of the Society of Toxicology.

Systematic Organization of COVID-19 Data Supported by the Adverse Outcome Pathway Framework

Stephen W. Edwards, C. Willett, Clemens Wittwehr, 2021, Frontiers in Public Health.

Building on a solid foundation: SAR and QSAR as a fundamental strategy to reduce animal testing$

C. Willett, K. Sullivan, J. Manuppello, 2014, SAR and QSAR in environmental research.

Applying evidence-based methods to the development and use of adverse outcome pathways.

Stephen W. Edwards, Katy O Goyak, Andrew A. Rooney, 2021, ALTEX.

Determination of thyroidal endocrine-disrupting chemicals (EDCs) activities using a human cell-based transactivation assay

C. Willett, Hee-Seok Lee, Yooheon Park, 2022, Environmental Sciences Europe.

Paving the way for application of next generation risk assessment to safety decision-making for cosmetic ingredients

S. H. Bennekou, V. Rogiers, K. Boekelheide, 2021, Regulatory toxicology and pharmacology : RTP.

Pathways of Toxicity.

Thomas Hartung, Roded Sharan, Melvin E Andersen, 2014, ALTEX.

Harvesting the promise of AOPs: An assessment and recommendations

Maurice Whelan, Gerald T. Ankley, Geoff Hodges, 2018, The Science of the total environment.

A look into the future of ALS research.

S. Lipnick, C. Willett, P. Clerc, 2016, Drug discovery today.

Development of an adverse outcome pathway from drug-mediated bile salt export pump inhibition to cholestatic liver injury.

Imran Shah, Brigitte Landesmann, Vera Rogiers, 2013, Toxicological sciences : an official journal of the Society of Toxicology.

A Systematic Review to Compare Chemical Hazard Predictions of the Zebrafish Embryotoxicity Test With Mammalian Prenatal Developmental Toxicity

M. Lalu, T. Hartung, M. Stephens, 2021, Toxicological sciences : an official journal of the Society of Toxicology.

Chemical hazard prediction and hypothesis testing using quantitative adverse outcome pathways.

Francis J Doyle, Lyle Burgoon, Francesco Falciani, 2019, ALTEX.

Adverse Outcome Pathways for Regulatory Applications: Examination of Four Case Studies With Different Degrees of Completeness and Scientific Confidence.

Francesco Falciani, Geoff Hodges, Dries Knapen, 2015, Toxicological sciences : an official journal of the Society of Toxicology.

REACHing for solutions: Essential revisions to the EU chemicals regulation to modernise safety assessment.

T. Seidle, C. Willett, D. Macmillan, 2022, Regulatory toxicology and pharmacology : RTP.

Advancing the adverse outcome pathway framework—An international horizon scanning approach

Sharon Munn, Carlie A. LaLone, Gerald T. Ankley, 2017, Environmental toxicology and chemistry.

Animal Use and Lessons Learned in the U.S. High Production Volume Chemicals Challenge Program

Patricia L Bishop, C. Willett, Patricia L. Bishop, 2012, Environmental health perspectives.

Exploring new technologies in biomedical research.

Qiang Zhang, Catherine Willett, Andre Kleensang, 2019, Drug discovery today.

Systematic Organization of COVID-19 Data Supported by the Adverse Outcome Pathway Framework

Stephen W. Edwards, C. Willett, Clemens Wittwehr, 2021, Frontiers in Public Health.

The use and acceptance of Other Scientifically Relevant Information (OSRI) in the U.S. Environmental Protection Agency (EPA) Endocrine Disruptor Screening Program.

Patricia L Bishop, C. Willett, Catherine E Willett, 2014, Birth defects research. Part B, Developmental and reproductive toxicology.

Tox21c: AOP Approach Applied to REACH

C. Willett, 2012 .

Building shared experience to advance practical application of pathway-based toxicology: liver toxicity mode-of-action.

Thomas Hartung, Imran Shah, Jennifer Seed, 2014, ALTEX.

Challenges and opportunities for overcoming dog use in agrochemical evaluation and registration.

Patricia L Bishop, T. Hartung, W. Casey, 2023, ALTEX.

A look into the future of ALS research.

S. Lipnick, C. Willett, Pascaline Clerc, 2016, Drug discovery today.

Pathways of Toxicity.

Yeyejide A. Adeleye, Scott M. Auerbach, M. Kanehisa, 2014, ALTEX.

Pathway-based toxicity: history, current approaches and liver fibrosis and steatosis as prototypes.

Brigitte Landesmann, Catherine Willett, Jessica Caverly Rae, 2014, ALTEX.

COVID-19 through Adverse Outcome Pathways: Building Networks to Better Understand the Disease – 3rd CIAO AOP Design Workshop

Young Jun Kim, Holly M. Mortensen, M. Vinken, 2022, ALTEX.

The Use of Adverse Outcome Pathways (AOPs) to Support Chemical Safety Decisions Within the Context of Integrated Approaches to Testing and Assessment (IATA)

Catherine Willett, C. Willett, 2018, Alternatives to Animal Testing.

Lessons learned, challenges, and opportunities: the U.S. Endocrine Disruptor Screening Program.

Melvin E Andersen, Richard A Becker, Thomas Hartung, 2014, ALTEX.

A discussion of the impact of US chemical regulation legislation on the field of toxicity testing.

Catherine Willett, Kristie Sullivan, Chad B. Sandusky, 2011, Toxicology in vitro : an international journal published in association with BIBRA.

Adverse Outcome Pathways: Development and Use in Toxicology

C. Willett, 2014 .

Building shared experience to advance practical application of pathway-based toxicology: liver toxicity mode-of-action.

Katy O Goyak, M. Vinken, P. Watkins, 2014, ALTEX.